STAT1 and neoplasm: These data taken together indicate that while impaired STAT1 signalling within lymphoid populations is likely to produce a deleterious effect in HNSCC, selective targeting of STAT1 signalling in HNSCC cells could potentially enhance anti-tumour immune responses and inhibit tumour cell growth.